Prime Healthcare Products Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 05-11-2024
- Paid Up Capital ₹ 1.50 M
as on 05-11-2024
- Company Age 5 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 159.43%
(FY 2023)
- Profit 157.41%
(FY 2023)
- Ebitda 212.54%
(FY 2023)
- Net Worth 71.17%
(FY 2023)
- Total Assets 0.41%
(FY 2023)
About Prime Healthcare Products
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Anjali Bansal and Ajay Bansal serve as directors at the Company.
- CIN/LLPIN
U33110DL2020PTC359660
- Company No.
359660
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Prime Healthcare Products Private Limited offer?
Prime Healthcare Products Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Medical Tubes, Disposable Cannulas.
Who are the key members and board of directors at Prime Healthcare Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjali Bansal  | Director | 01-Jan-2020 | Current |
| Ajay Bansal | Director | 01-Jan-2020 | Current |
Financial Performance of Prime Healthcare Products.
Prime Healthcare Products Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 159.43% increase. The company also saw a substantial improvement in profitability, with a 157.41% increase in profit. The company's net worth Soared by an impressive increase of 71.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prime Healthcare Products?
Unlock access to Prime Healthcare Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Prominent Buildwell Private LimitedActive 19 years 10 monthsAnjali Bansal and Ajay Bansal are mutual person
- Nidhi Prime Infraprojects Private LimitedActive 17 years 5 months
Anjali Bansal and Ajay Bansal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prime Healthcare Products?
Prime Healthcare Products has a workforce of 6 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prime Healthcare Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prime Healthcare Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
